144 related articles for article (PubMed ID: 35680387)
1. Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease.
Wiebe E; Huscher D; Schaumburg D; Palmowski A; Hermann S; Buttgereit T; Biesen R; Burmester GR; Palmowski Y; Boers M; Stone JH; Dejaco C; Buttgereit F
Ann Rheum Dis; 2022 Aug; 81(9):1313-1322. PubMed ID: 35680387
[TBL] [Abstract][Full Text] [Related]
2. Bone Loss in Inflammatory Rheumatic Musculoskeletal Disease Patients Treated With Low-Dose Glucocorticoids and Prevention by Anti-Osteoporosis Medications.
Adami G; Fassio A; Rossini M; Benini C; Pistillo F; Viapiana O; Bertelle D; Gatti D
Arthritis Rheumatol; 2023 Oct; 75(10):1762-1769. PubMed ID: 37094379
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoids Are Not Associated with Bone Mineral Density in Patients with Polymyalgia Rheumatica, Giant Cell Arteritis and Other Vasculitides-Cross-Sectional Baseline Analysis of the Prospective Rh-GIOP Cohort.
Palmowski A; Wiebe E; Muche B; Hermann S; Dejaco C; Matteson EL; Buttgereit F
Cells; 2022 Feb; 11(3):. PubMed ID: 35159345
[TBL] [Abstract][Full Text] [Related]
4. Sex and age do not modify the association between glucocorticoids and bone mineral density in patients with rheumatoid arthritis: a cross-sectional study.
Palmowski A; Boyadzhieva Z; Nielsen SM; Muche B; Hermann S; Boers M; Bliddal H; Christensen R; Wiebe E; Buttgereit F
Arthritis Res Ther; 2023 Jun; 25(1):98. PubMed ID: 37287080
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk factors associated with glucocorticoid-induced osteoporosis in Chinese patients with rheumatoid arthritis.
Ma CC; Xu SQ; Gong X; Wu Y; Qi S; Liu W; Xu JH
Arch Osteoporos; 2017 Dec; 12(1):33. PubMed ID: 28374332
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study.
Rossini M; Viapiana O; Vitiello M; Malavolta N; La Montagna G; Maddali Bongi S; Di Munno O; Nuti R; Manzini CU; Ferri C; Bogliolo L; Mathieu A; Cantatore F; Del Puente A; Muratore M; Grassi W; Frediani B; Saviola G; Delvino P; Mirone L; Ferraccioli G; Tripi G; Piazza I; Gatti D
Reumatismo; 2017 May; 69(1):30-39. PubMed ID: 28535619
[TBL] [Abstract][Full Text] [Related]
7. Does low-dose and short-term glucocorticoids treatment increase the risk of osteoporosis in rheumatoid arthritis female patients?
Korczowska I; Olewicz-Gawlik A; Trefler J; Hrycaj P; Krzysztof Łacki J
Clin Rheumatol; 2008 May; 27(5):565-72. PubMed ID: 17909741
[TBL] [Abstract][Full Text] [Related]
8. Influence of glucocorticoid treatment on trabecular bone score and bone remodeling regulators in early rheumatoid arthritis.
Corrado A; Rotondo C; Mele A; Cici D; Maruotti N; Sanpaolo E; Colia R; Cantatore FP
Arthritis Res Ther; 2021 Jul; 23(1):180. PubMed ID: 34229744
[TBL] [Abstract][Full Text] [Related]
9. Anti-Inflammatory Effects of Low-Dose Glucocorticoids Compensate for Their Detrimental Effects on Bone Mineral Density in Patients with Rheumatoid Arthritis.
Kim JW; Jung JY; Kim HA; Suh CH
J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34209074
[TBL] [Abstract][Full Text] [Related]
10. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of body composition and bone mineral density in women with rheumatoid arthritis].
Silva RG; Pippa MG; Zerbin CA
Rev Assoc Med Bras (1992); 2007; 53(2):135-41. PubMed ID: 17568917
[TBL] [Abstract][Full Text] [Related]
12. No association between methotrexate and impaired bone mineral density in a cohort of patients with polymyalgia rheumatica, giant cell arteritis, granulomatosis with polyangiitis and other vasculitides-a cross-sectional analysis with dose-response analyses.
Palmowski A; Akahoshi M; Muche B; Boyadzhieva Z; Hermann S; Terao C; Wiebe E; Buttgereit F
Rheumatol Int; 2023 May; 43(5):903-909. PubMed ID: 36811660
[TBL] [Abstract][Full Text] [Related]
13. Proton Pump Inhibitor Use and Bone Health in Patients With Rheumatic Diseases: A Cross-Sectional Study.
Palmowski A; Schmajuk G; Yazdany J; Katz P; Li J; Stovall R; Kersey E; Nielsen SM; Christensen R; Bliddal H; Boyadzhieva Z; Schneider U; Alexander T; Muche B; Hermann S; Wiebe E; Buttgereit F
Mayo Clin Proc; 2024 Apr; ():. PubMed ID: 38752948
[TBL] [Abstract][Full Text] [Related]
14. Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis.
Book C; Karlsson M; Akesson K; Jacobsson L
Scand J Rheumatol; 2008; 37(4):248-54. PubMed ID: 18612924
[TBL] [Abstract][Full Text] [Related]
15. Changes in bone mineral density following discontinuation or continuation of alendronate therapy in glucocorticoid-treated patients: a retrospective, observational study.
Emkey R; Delmas PD; Goemaere S; Liberman UA; Poubelle PE; Daifotis AG; Verbruggen N; Lombardi A; Czachur M
Arthritis Rheum; 2003 Apr; 48(4):1102-8. PubMed ID: 12687554
[TBL] [Abstract][Full Text] [Related]
16. A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass.
Ibañez M; Ortiz AM; Castrejón I; García-Vadillo JA; Carvajal I; Castañeda S; González-Alvaro I
Arthritis Res Ther; 2010; 12(2):R50. PubMed ID: 20331862
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and risk factors associated with vertebral osteoporotic fractures in patients with rheumatoid arthritis.
Tong JJ; Xu SQ; Zong HX; Pan MJ; Teng YZ; Xu JH
Clin Rheumatol; 2020 Feb; 39(2):357-364. PubMed ID: 31691041
[TBL] [Abstract][Full Text] [Related]
18. Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the disease.
Kroot EJ; Nieuwenhuizen MG; de Waal Malefijt MC; van Riel PL; Pasker-de Jong PC; Laan RF
Arthritis Rheum; 2001 Jun; 44(6):1254-60. PubMed ID: 11407683
[TBL] [Abstract][Full Text] [Related]
19. Discriminative ability of trabecular bone score over bone mineral density for vertebral and fragility fracture in patients treated with long-term and low-dose glucocorticoid.
Lee KA; Kim J; Kim HJ; Kim HS
Int J Rheum Dis; 2021 Aug; 24(8):1053-1060. PubMed ID: 34184827
[TBL] [Abstract][Full Text] [Related]
20. Short-term, high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis.
Olsson A; Oturai DB; Sørensen PS; Oturai PS; Oturai AB
Mult Scler; 2015 Oct; 21(12):1557-65. PubMed ID: 25623251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
